ZA927779B - Osmotic drug delivery devices with hydrophobic wall materials. - Google Patents

Osmotic drug delivery devices with hydrophobic wall materials.

Info

Publication number
ZA927779B
ZA927779B ZA927779A ZA927779A ZA927779B ZA 927779 B ZA927779 B ZA 927779B ZA 927779 A ZA927779 A ZA 927779A ZA 927779 A ZA927779 A ZA 927779A ZA 927779 B ZA927779 B ZA 927779B
Authority
ZA
South Africa
Prior art keywords
drug delivery
delivery devices
wall materials
osmotic drug
hydrophobic wall
Prior art date
Application number
ZA927779A
Other languages
English (en)
Inventor
Eun Soo Lee
Scott A Bura
Su Il Yum
Patrick S L Wong
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA927779B publication Critical patent/ZA927779B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
ZA927779A 1991-10-10 1992-10-09 Osmotic drug delivery devices with hydrophobic wall materials. ZA927779B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77563591A 1991-10-10 1991-10-10

Publications (1)

Publication Number Publication Date
ZA927779B true ZA927779B (en) 1993-07-05

Family

ID=25105009

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927779A ZA927779B (en) 1991-10-10 1992-10-09 Osmotic drug delivery devices with hydrophobic wall materials.

Country Status (10)

Country Link
US (1) US5795591A (fr)
EP (1) EP0607321A1 (fr)
JP (1) JPH07500264A (fr)
AU (1) AU2867492A (fr)
CA (1) CA2115648C (fr)
MX (1) MX9205850A (fr)
NZ (1) NZ244682A (fr)
PT (1) PT100944B (fr)
WO (1) WO1993006819A1 (fr)
ZA (1) ZA927779B (fr)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022424A1 (fr) * 1993-03-29 1994-10-13 Alza Corporation Membrane biodegradable, permeable a l'eau pour pompe a absorption de fluide
ATE196077T1 (de) 1993-07-22 2000-09-15 Pfizer Osmotische vorrichtung mit dampfdurchlaessiger beschichtung
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
US6395292B2 (en) * 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6132420A (en) * 1996-02-02 2000-10-17 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
ZA9710342B (en) * 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US5954966A (en) * 1997-01-31 1999-09-21 University Of Ottawa Membrane composition and method of preparation
EP1325741B1 (fr) * 1997-03-24 2007-06-06 Alza Corporation Dispositif d' administration implantable à orifice de sortie autoréglable
ZA981610B (en) * 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
PT1140012E (pt) * 1998-12-17 2004-05-31 Alza Corp Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
US6491683B1 (en) * 1999-09-07 2002-12-10 Alza Corporation Osmotic dosage form composed of an extruded polymer tube form
ES2248156T3 (es) 1999-12-21 2006-03-16 Alza Corporation Valvula para dispositivos osmoticos.
EP1967185A1 (fr) * 1999-12-23 2008-09-10 Pfizer Products Inc. Forme de dosage de médicament entraîné par un hydrogél
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
US6737084B2 (en) 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response
CA2434169C (fr) * 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Systeme de liberation espacee de medicaments
EP1372753B1 (fr) 2001-02-16 2007-08-01 Abbott Laboratories Vascular Enterprises Limited Implants avec fk506 pour la prophylaxie et le traitement de la restenose
CA2443632C (fr) * 2001-04-10 2011-05-03 Sun Pharmaceutical Industries Limited Composition a liberation par impulsion reglee dans le temps
US6632217B2 (en) 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
WO2003000156A1 (fr) * 2001-06-22 2003-01-03 Southern Biosystems, Inc. Implants coaxiaux a liberation prolongee d'ordre 0
US6949154B2 (en) * 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
US20030064095A1 (en) 2001-09-14 2003-04-03 Imedd, Inc. Microfabricated nanopore device for sustained release of therapeutic agent
TWI222997B (en) * 2001-12-10 2004-11-01 Ind Tech Res Inst Method for tissue culture in vitro
WO2003105803A1 (fr) * 2002-06-17 2003-12-24 Alza Corporation Systeme de distribution controle par la pression osmotique avec moteur a puissance de poussee precoce d'ordre zero comprenant un agent osmotique disperse dans le vehicule fluidique
DE60317225T2 (de) * 2002-06-26 2008-05-29 Intarcia Therapeutics, Inc., Emeryville Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
US20040133270A1 (en) * 2002-07-08 2004-07-08 Axel Grandt Drug eluting stent and methods of manufacture
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7037521B2 (en) * 2003-03-28 2006-05-02 Bausch & Lomb Incorporated Using a laser for cutting a hole in a capsule for controlled drug delivery
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7922702B2 (en) 2004-07-02 2011-04-12 Qlt Inc. Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
US7117870B2 (en) * 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
DE102004042578A1 (de) * 2004-09-02 2006-03-23 Roche Diagnostics Gmbh Mikropumpe zur Förderung von Flüssigkeiten mit niedrigen Förderraten im Druck/Saug-Betrieb
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US20080009423A1 (en) 2005-01-31 2008-01-10 Halliburton Energy Services, Inc. Self-degrading fibers and associated methods of use and manufacture
WO2006083761A2 (fr) 2005-02-03 2006-08-10 Alza Corporation Solutions de solvant/polymere utilisees comme vehicules de suspension
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
EP2359808B1 (fr) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Système de libération osmotique avec ensemble de piston
CA2671092A1 (fr) * 2006-11-30 2008-06-05 Accu-Break Technologies, Inc. Formes de dosage osmotique divisibles et leur procede d'utilisation
WO2008133908A2 (fr) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Formulations en suspension de peptides insulinotropes et leurs utilisations
US9586035B2 (en) 2007-12-11 2017-03-07 Massachusetts Institute Of Technology Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
CA2726861C (fr) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Dispositifs, formulations et methodes d'administration de plusieurs agents benefiques
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
CN102470237A (zh) 2009-06-26 2012-05-23 塔里斯生物医药公司 用于可植入药物递送装置的固体药物片剂
EP2461818B1 (fr) 2009-08-03 2018-10-17 Incube Labs, Llc Capsule ingérable et procédé pour stimuler la production d'incrétine à l'intérieur du tractus intestinal
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
PL3884988T3 (pl) 2009-12-17 2025-09-08 Taris Biomedical Llc Urządzenie implantowalne z tolerancją wewnątrzpęcherzową
US8759284B2 (en) 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) * 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9114111B2 (en) 2011-01-10 2015-08-25 Allergan, Inc. Methods for sustained treatment of bladder pain and irritative voiding
AU2012211960B2 (en) 2011-02-04 2016-12-01 Taris Biomedical Llc Implantable device for controlled release of low solubility drug
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
PT2968880T (pt) 2013-03-15 2025-07-07 Taris Biomedical Llc Dispositivos de aplicação de fármaco com componente permeável a fármaco
CN113413393B (zh) 2013-08-19 2025-03-04 塔里斯生物医药公司 多单元药物递送装置和方法
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
US10143804B2 (en) 2015-05-29 2018-12-04 ZebraSci, Inc Biopolymer-based emulsion lubricants for syringe barrels
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
EP3518943A4 (fr) 2016-09-28 2020-04-22 Atossa Therapeutics, Inc. Méthodes de thérapie cellulaire adoptive
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991766A (en) * 1973-05-31 1976-11-16 American Cyanamid Company Controlled release of medicaments using polymers from glycolic acid
US4135514A (en) * 1974-12-23 1979-01-23 Alza Corporation Osmotic releasing system for administering ophthalmic drug to eye of animal
US4034758A (en) * 1975-09-08 1977-07-12 Alza Corporation Osmotic therapeutic system for administering medicament
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4220153A (en) * 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4400374A (en) * 1979-06-22 1983-08-23 Environmental Chemicals, Inc. Controlled release of compounds utilizing a plastic matrix
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
DK90883A (da) * 1982-03-18 1983-09-19 Merck & Co Inc Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4552752A (en) * 1983-01-31 1985-11-12 Rohm And Haas Company Microbiocidal article for aqueous systems
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4656057A (en) * 1983-07-28 1987-04-07 Rohm And Haas Company Microbiocidal article for aqueous systems
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US5008112A (en) * 1985-12-16 1991-04-16 International Minerals & Chem. Corporation Device for the extended delivery of diffusible agents
US5145945A (en) * 1987-12-17 1992-09-08 Allied-Signal Inc. Homopolymers and copolymers having recurring carbonate units
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5223266A (en) * 1990-01-24 1993-06-29 Alza Corporation Long-term delivery device with early startup

Also Published As

Publication number Publication date
PT100944A (pt) 1994-06-30
NZ244682A (en) 1993-12-23
WO1993006819A1 (fr) 1993-04-15
AU2867492A (en) 1993-05-03
US5795591A (en) 1998-08-18
JPH07500264A (ja) 1995-01-12
MX9205850A (es) 1993-06-01
EP0607321A1 (fr) 1994-07-27
CA2115648C (fr) 2002-04-09
PT100944B (pt) 2000-02-29
CA2115648A1 (fr) 1993-04-15

Similar Documents

Publication Publication Date Title
ZA927779B (en) Osmotic drug delivery devices with hydrophobic wall materials.
US5525634B1 (en) Colonic drug delivery system
GR3018890T3 (en) Medicament dispensing device.
EP0670716A4 (fr) Substances pharmaceutiques au gout camoufle.
ZA926020B (en) Pharmaceutical combination formulation.
AU2937892A (en) Polymer-based osmotic drug delivery system
IL109661A0 (en) Drug delivery device
EP0662851A4 (fr) Systeme d'administration de medicaments.
GR3036937T3 (en) Pharmaceutical formulations.
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
EP0523943A3 (en) Pharmaceutical container
ZA927562B (en) Medicament.
GB9117717D0 (en) Dispenser pumps
ZA936620B (en) Medicament dispensing device.
EP0524987A4 (en) Eriodictyon drug delivery systems
EP0523942A3 (en) Pharmaceutical container
EP0613445A4 (fr) Distributeur.
GB9109021D0 (en) Dosing pump
ZA929294B (en) Syringe.
DE69217020D1 (de) Arzneimittel mit gesteuerter Wirkstoffabgabe
ZA927506B (en) New drug formulation.
ZA929724B (en) Ballisitc materials.
GB9104226D0 (en) Liquid delivery system
EP0600754A3 (fr) Transfuseur pharmaceutique à débit continu.
EP0636363A3 (fr) Système pour la délivrance d'un médicament.